Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner on the deal. Baker McKenzie advised Xbrane Biopharma. Xbrane Biopharma AB successfully carried…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
